Literature DB >> 7697250

Correlation of structure and function in idiopathic pulmonary fibrosis.

R M Cherniack1, T V Colby, A Flint, W M Thurlbeck, J A Waldron, L Ackerson, M I Schwarz, T E King.   

Abstract

The early stage of idiopathic pulmonary fibrosis (IPF) is thought to involve a smaller number of alveoli and to be characterized predominantly by cellularity and minimal fibrosis, whereas advanced disease involves a large number of alveoli and is characterized predominantly by fibrosis with minimal cellularity. In addition, correlative studies have indicated that prognosis and response to therapy is determined in part by the extent of fibrosis and cellularity. This study was undertaken to determine whether pulmonary function assessment would help distinguish between the cellular and fibrotic phases of this disorder, as determined by a semiquantitative pathology scoring system that comprised four factor scores: fibrosis, cellularity, granulation/connective tissue, and desquamation. Ninety-six untreated patients with biopsy-confirmed IPF (27 never smokers, 32 current smokers, and 37 ex-smokers) were evaluated. In the group as a whole, there was no significant relationship between the fibrosis or the connective/granulation tissue factor scores and any of the physiologic parameters. The DLCO correlated with the "desquamation" and the total pathology scores, whereas the TLC and FVC correlated with the cellularity factor score. In the current smokers, the coefficient of elastic retraction, DLCO/VA, and FEV1/FVC ratio were significantly lower than in never smokers and ex-smokers, and TLC and FVC were higher than in never smokers. Also, the mean cellularity and granulation/connective tissue factor scores were significantly lower, and the desquamation factor score was significantly higher than those in never smokers and ex-smokers. Both age and smoking status were significant for the cellularity factor score, whereas for the connective/granulation tissue factor score, age was not significant but smoking status was.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7697250     DOI: 10.1164/ajrccm/151.4.1180

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  16 in total

Review 1.  Review of cryptogenic fibrosing alveolitis, including current treatment guidelines.

Authors:  S C Bourke; H Clague
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

2.  Smoking-related idiopathic interstitial pneumonia.

Authors:  Kevin R Flaherty; Charlene Fell; Marie-Christine Aubry; Kevin Brown; Thomas Colby; Ulrich Costabel; Teri J Franks; Barry H Gross; David M Hansell; Ella Kazerooni; Dong Soon Kim; Talmadge E King; Masanori Kitachi; David Lynch; Jeff Myers; Sonoko Nagai; Andrew G Nicholson; Venerino Poletti; Ganesh Raghu; Moises Selman; Galen Toews; William Travis; Athol U Wells; Robert Vassallo; Fernando J Martinez
Journal:  Eur Respir J       Date:  2014-07-25       Impact factor: 16.671

Review 3.  Pulmonary function testing in idiopathic interstitial pneumonias.

Authors:  Fernando J Martinez; Kevin Flaherty
Journal:  Proc Am Thorac Soc       Date:  2006-06

4.  Cryptogenic fibrosing alveolitis with preserved lung volumes.

Authors:  M J Doherty; M G Pearson; E A O'Grady; V Pellegrini; P M Calverley
Journal:  Thorax       Date:  1997-11       Impact factor: 9.139

5.  Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts.

Authors:  D W Mapel; W C Hunt; R Utton; K B Baumgartner; J M Samet; D B Coultas
Journal:  Thorax       Date:  1998-06       Impact factor: 9.139

6.  Serum inter-alpha-trypsin inhibitor and matrix hyaluronan promote angiogenesis in fibrotic lung injury.

Authors:  Stavros Garantziotis; Enrique Zudaire; Carol S Trempus; John W Hollingsworth; Dianhua Jiang; Lisa H Lancaster; Elizabeth Richardson; Lisheng Zhuo; Frank Cuttitta; Kevin K Brown; Paul W Noble; Koji Kimata; David A Schwartz
Journal:  Am J Respir Crit Care Med       Date:  2008-08-14       Impact factor: 21.405

7.  Patterns of pulmonary function in smoking and nonsmoking patients with progressive systemic sclerosis.

Authors:  Silvia A Quadrelli; Luciana Molinari; Lorena M Ciallella; Martin Bosio; Alejandro Salvado
Journal:  Rheumatol Int       Date:  2009-01-08       Impact factor: 2.631

8.  Visual score and quantitative CT indices in pulmonary fibrosis: Relationship with physiologic impairment.

Authors:  N Sverzellati; E Calabrò; A Chetta; G Concari; A R Larici; M Mereu; R Cobelli; M De Filippo; M Zompatori
Journal:  Radiol Med       Date:  2007-12-13       Impact factor: 3.469

9.  Do we need exercise tests to detect gas exchange impairment in fibrotic idiopathic interstitial pneumonias?

Authors:  Benoit Wallaert; Lidwine Wemeau-Stervinou; Julia Salleron; Isabelle Tillie-Leblond; Thierry Perez
Journal:  Pulm Med       Date:  2012-07-29

10.  Clinical analysis of interstitial pneumonia after surgery for lung cancer.

Authors:  Taku Okamoto; Masashi Gotoh; Daiki Masuya; Takashi Nakashima; Dage Liu; Kotaro Kameyama; Shinya Ishikawa; Yasumichi Yamamoto; Cheng-Long Huang; Hiroyasu Yokomise
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2004-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.